The above results indicate the up‐regulated expression of DDX17 and the down‐regulated expression of Cyp2c29 in the livers of human individuals and murine NASH models, when compared with their corresponding controls. Here, DDX17 is linked to metabolic dysfunction-associated steatohepatitis.